In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diethanolamine Should Stay Off Prop 65 List While Under FDA Review - CHPA

This article was originally published in The Tan Sheet

Executive Summary

A safety ruling on diethanolamine (DEA) by California's Office of Environmental Health Hazard Assessment (OEHHA) would be premature while the cosmetic and OTC drug ingredient is undergoing FDA review, the Consumer Healthcare Products Association asserts in April 6 comments to the state agency.

You may also be interested in...



DEA Carcinogenicity Evidence Limited To "One Study, One Species" - CTFA

Animal data indicating diethanolamine may be a human carcinogen are limited to "one study in one species, with...one route of exposure," the Cosmetic, Toiletry & Fragrance Association points out in Sept. 17 comments to the National Toxicology Program.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS089702

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel